Inhibition of CYP 17, a new strategy for the treatment of prostate cancer.
Hartmann RW, Ehmer PB, Haidar S, Hector M, Jose J, Klein CD, Seidel SB, Sergejew TF, Wachall BG, Wächter GA, Zhuang Y.
Hartmann RW, et al. Among authors: jose j.
Arch Pharm (Weinheim). 2002 Apr;335(4):119-28. doi: 10.1002/1521-4184(200204)335:4<119::AID-ARDP119>3.0.CO;2-#.
Arch Pharm (Weinheim). 2002.
PMID: 12112031
Review.